Texas Instruments Incorporated
—- Market cap
- —
- Debt
- +$14.05B
- Cash
- −$3.23B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TXN stock price vs KEYS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KEYS's multiple
Needs KEYS P/E.
Implied fair value · at TXN's multiple
Needs TXN P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TEXAS INSTRUMENTS INCORPORATED · implied price per share
Bear
$20.64
Base
$24.46
Bull
$31.23
KEYSIGHT TECHNOLOGIES, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TXN can sustain its higher margins and 13.0% revenue growth while maintaining ROIC above KEYS, then holding or accumulating makes sense because the operating quality is clearly better even though valuation is rich relative to sales and DCF ranges.
On KEYS relative valuation, TXN appears expensive: its P/E of 50.6x is below KEYS at 65.0x, but TXN also carries a much higher P/S of 14.2x versus 10.1x and a higher EV/Revenue of 14.8x versus 10.1x. The implied price of $354.17 suggests 28.4% upside from $275.74, yet that sits above the historical band midpoint and far above the DCF range.
Supporting Metrics